• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Manufacturing
    • Packaging
    • Development
    • Compliance
    • Top 20
    • Directory
    • Microsites
    • Events
    • More
  • Magazine
  • News
  • Manufacturing
  • Packaging
  • Development
  • Compliance
  • Top 20
  • Directory
  • Microsites
  • Events
  • Current / Back Issue
    Features
    Editorial
    Columns
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Subscribe Now
    Advertise Now
    Top Features
    Newsmakers: Darren Shirley

    Are You Prepared for the 2023 DSCSA Deadline?

    Rethinking the Changing Role of the CRO

    23rd Annual Salary Survey

    Pharma 4.0 and the Modernizing Power of Digital Technology Transfer
    Breaking News
    Online Exclusives
    Industry News
    Collaborations & Alliances
    Promotions & Moves
    Trials & Filings
    Financial Reports
    Bio News & Views
    Custom Sourcing News
    Packaging & Tracking
    CRO News
    Live From Shows
    Top News
    Takeda to Expand U.S. Footprint

    Croda Pharma's Lipid Systems Capability to Support mRNA Vaccines

    WuXi STA Opens High-Potency API Plant

    Catalent Expands Primary Packaging Capabilities at its Shiga, Japan Facility

    Phastar Appoints Chris Schoonmaker as Chief Operations Officer
    APIs
    Aseptic Processing
    Cleaning Validation
    Clinical Trial Materials
    Cytotoxics and High Potency Manufacturing
    Equipment
    Excipients
    Extractables and Leachables
    Facilities
    Fill/Finish
    Lyophilization
    Parenterals
    Process Development
    Process Validation
    Risk Management
    Scale-up/ Technology Transfer
    Solid Dosage/ Creams/ Ointments

    Takeda to Expand U.S. Footprint

    Croda Pharma's Lipid Systems Capability to Support mRNA Vaccines

    WuXi STA Opens High-Potency API Plant

    Catalent Expands Primary Packaging Capabilities at its Shiga, Japan Facility

    Shimadzu Scientific Instruments Extends HQ Campus
    Capsules
    Cold Chain Management
    Injectables
    Logistics
    Serialization
    Solid Dosage / Semi-solids
    Supply Chain
    Vials

    Tubular Glass Primary Packaging for Pharmaceutical, Biotech and Diagnostic Containment

    How to Improve the Cold Chain System in Remote Locations

    Sentry Biopharma Services: Protecting Pharmaceutical Integrity

    Yourway to Build New Flagship European Depot

    Newsmakers: Darren Shirley
    Analytical Services
    Bioanalytical Services
    Bioassay Developement
    Biologics, Proteins, Vaccines
    Biosimilars
    Chemistry
    Clinical Trials
    Drug Delivery
    Drug Development
    Drug Discovery
    Formulation Development
    Information Technology
    Laboratory Testing
    Methods Development
    Microbiology
    Preclinical Outsourcing
    R&D
    Toxicology

    Takeda to Expand U.S. Footprint

    Croda Pharma's Lipid Systems Capability to Support mRNA Vaccines

    Charles River Labs Opens Plasmid DNA CoE in Cheshire, UK

    EQT Private Equity Acquires SPT Labtech from Battery Ventures

    Ixaka & Minaris Sign Tech Transfer & GMP Manufacturing Agreement for Cell Therapy Candidate
    Filtration & Purification
    GMPs/GCPs
    Inspections
    QA/QC
    Regulatory Affairs
    Validation

    Should Remote Pharma GMP Audits End After COVID?

    Why is Big Pharma Increasingly Adopting 505(b)(2)?

    Sentry Biopharma Services: Protecting Pharmaceutical Integrity

    Selkirk Pharma Appoints New Head of Quality

    Be Safer by Doing Less: The Future of Zero Touch AE Case Processing
    Companies
    Categories
    Corporate Capabilities
    Add New Company
    Contract Service Directory Companies
    Kyongbo Pharmaceutical

    Societal CDMO

    Baxter BioPharma Solutions

    Vector Partners Limited

    Qosina
    Companies
    News Releases
    Posters
    Brochures
    Services
    Videos
    Case Study
    White Papers
    Jobs
    Contract Service Directory Companies
    Kyongbo Pharmaceutical

    Societal CDMO

    Baxter BioPharma Solutions

    Vector Partners Limited

    Qosina
    Webinars
    Live From Shows
    • Magazine
      • Current / Back Issue
      • Features
      • Editorial
      • Columns
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
      • Enewsletter Archive
      • Digital Edition
    • Directory
      • Companies
      • Categories
      • Corporate Capabilities
      • Add Your Company
    • Manufacturing
      • APIs
      • Aseptic Processing
      • Cleaning Validation
      • Clinical Trial Materials
      • Cytotoxics and High Potency Manufacturing
      • Equipment
      • Excipients
      • Extractables and Leachables
      • Facilities
      • Fill/Finish
      • Lyophilization
      • Parenterals
      • Process Development
      • Process Validation
      • Risk Management
      • Scale-up/ Technology Transfer
      • Solid Dosage/ Creams/ Ointments
      • cGMP Manufacture
    • Packaging
      • Capsules
      • Cold Chain Management
      • Injectables
      • Logistics
      • Serialization
      • Solid Dosage / Semi-solids
      • Supply Chain
      • Vials
    • Development
      • Analytical Services
      • Bioanalytical Services
      • Bioassay Developement
      • Biologics, Proteins, Vaccines
      • Biosimilars
      • Chemistry
      • Clinical Trials
      • Drug Delivery
      • Drug Development
      • Drug Discovery
      • Formulation Development
      • Information Technology
      • Laboratory Testing
      • Methods Development
      • Microbiology
      • Preclinical Outsourcing
      • R&D
      • Toxicology
    • Compliance
      • Filtration & Purification
      • GMPs/GCPs
      • Inspections
      • QA/QC
      • Regulatory Affairs
      • Validation
    • Top 25 Pharma & BioPharma
    • Contract Pharma Direct
    • Breaking News
    • Online Exclusives
    • Slideshows
    • Experts Opinions
    • Surveys
      • Outsourcing Survey
      • Salary Survey
    • Glossary
    • Videos
    • White Papers
    • Podcasts
    • Infographics
    • Supplier Microsite
      • Companies
      • News Releases
      • Posters
      • Brochures
      • Services
      • Videos
      • Case Study
      • White Papers
    • Contract Pharma Conference
      • Contract Pharma Conference
      • Speakers
      • Exhibitors
      • Conference Sessions
    • eBook
    • Webinars
    • Events
      • Industry Events
      • Live from Show Events
      • Webinars
    • Classifieds / Job Bank
      • Classifieds
      • Job Bank
    • About Us
      • About Us
      • Contact Us
      • Advertise With Us
      • Privacy Policy
      • Terms of Use
    Online Exclusives

    Primary Packaging Considerations Amid COVID-19 Vax Urgency

    Fran L. DeGrazio of West discusses why and how vaccine development is different than drug development and the impacts of COVID-19 on vaccine development.

    Primary Packaging Considerations Amid COVID-19 Vax Urgency
    Related CONTENT
    • Bora Pharmaceuticals
    • Legacy Pharma Solutions
    • Applied Laboratories
    • PCI Pharma Services
    • J&J Data Confirms Strong and Long-Lasting Protection of COVID-19 Vax
    Kristin Brooks, Contract Pharma10.05.20

    Vaccine development differs widely from drug development in many ways, including packaging, storage and distribution. Primary packaging plays a critical role in the stability of vaccines and COVID-19 has created an urgency that disrupts standard evaluation of potential packaging systems.

    Fran L. DeGrazio, Chief Scientific Officer at West Pharmaceutical Services discusses why and how vaccine development is different than drug development, and the nuances of vaccine development in the current landscape regarding COVID-19. –KB  

    Contract Pharma: How does vaccine development differ from drug development? What key distinctions does vaccine development entail?

    Fran L. DeGrazio: While overlap exists across certain elements critical to the development process for vaccines and drugs, many key nuances differ between the two. Vaccines in general tend to be more temperature-sensitive, for example, which triggers the need to maintain a secure “cold chain” during storage, handling, and transportation.

    Further, the pure scale of vaccine development and production is significantly larger than that of a single new drug – from the number of involved resources to the number of units produced, storage needs, access and beyond.

    CP: How is the current landscape regarding COVID-19 impacting vaccine development?

    FD: Development and distribution of a vaccine for SARS-CoV-2 presents challenges that are wholly unprecedented and impact the industry at large, as all players – from contract manufacturers to pharmaceutical and biotech companies to clinicians/scientists – must adapt accordingly in order to deliver a safe and effective vaccine as quickly as possible.

    First and foremost, there is an unparalleled sense of urgency, given the impact to-date and potential future implications of this pandemic, which is driving vaccine R&D at speeds unlike anything seen even in fast-tracked drug development. And this in turn impacts all aspects of development.

    Other challenges being mitigated on the path to discovering a viable vaccine include issues concerning package selection and systems, as well as storage. Typically, selecting a package system for a vaccine platform may not present as many complicating factors – as ample time would be available for evaluation of compatibility with the vaccine. However, for SARS-CoV-2, regardless of whether the vaccine platform being studied and potentially used already exists or is new, these evaluations are being accelerated. This can create varying degrees of added risk.

    For example, the selection of vial/stopper primary package systems from manufacturing through delivery is a key consideration in vaccine development. However, specific to SARS-CoV-2, this selection process becomes compounded by expedited timelines, in addition to the fact that various technologies and platforms are being explored – each of which may have different requirements to assure stability, quality and delivery.

    An example of this is that typically, primary package systems for vaccines employ glass vials. But, with the increased demand resultant from the SARS-CoV-2 pandemic, potential glass vial shortages and unacceptable lead times, alternatives such as polymer vials may also need to be considered.

    CP: How is the COVID-19 pandemic impacting West’s products/services/operations?

    FD: We are committed to doing our part to speed the successful development and large-scale manufacture of high-quality components required to serve customer needs for the delivery of a safe and effective SARS-CoV-2 vaccine, which includes expanding labor and equipment resources.

    In an effort to best support our customers investigating potential vaccine candidates for SARS-CoV-2, West has made it a practice to preemptively assess needs, evaluate which of our products and services could be most of use and ensure operations are available at needed scale.

    For instance, across the six platforms currently being considered for SARS-CoV-2 vaccine candidates, West offers product solutions that may help optimize quality to safety from manufacture through delivery in the midst of compressed timelines. This includes offerings that can mitigate the migration of leachables from and interactions between the closure and the vaccine product, while enabling proven package system container closure integrity. And many of our relevant products are already globally available and market accepted, with options available in varying sizes and configurations – which may help reduce certain risk, since accelerated vaccine development timelines cannot accommodate standard evaluation within potential packaging systems.

    As the COVID-19 situation continues to evolve, we remain committed to supporting and delivering for our customers, patients, and employees – while never compromising on safety. Our teams are constantly monitoring to ensure we have the most optimal protocols in place within our operations in accordance with guidance from leading experts, and are working to help minimize the impact of potential logistical and supply challenges that may arise outside of our scope of control.

    This also includes capital investments to shore up areas of our robust manufacturing program as needed, as demand for supplies needed for use with treatments to combat COVID-19 has increased across the board – even beyond vaccine development.
     


    Fran DeGrazio has 35+ years of experience in the pharmaceutical packaging and delivery industry, with extensive expertise in injectable drug products, including vial container closure systems and prefillable systems for combination products.  Fran has held numerous technical roles at West, including R&D, Quality & Regulatory, Technical Customer Support, Analytical Laboratories and Scientific Affairs.  In her current role as Chief Scientific Officer, she is responsible to leverage scientific and regulatory understanding across the enterprise.  Fran received the Philadelphia Business Journal 2018 Healthcare Innovators of the Greater Philadelphia Region Award and the Healthcare Business Woman’s Association Luminary Award for West in 2017.

    Suggested For You
    Bora Pharmaceuticals Bora Pharmaceuticals
    Legacy Pharma Solutions Legacy Pharma Solutions
    Applied Laboratories Applied Laboratories
    PCI Pharma Services PCI Pharma Services
    J&J Data Confirms Strong and Long-Lasting Protection of COVID-19 Vax J&J Data Confirms Strong and Long-Lasting Protection of COVID-19 Vax
    BioVaxys Reports Progress on Covid-19 Vax Candidate BioVaxys Reports Progress on Covid-19 Vax Candidate
    CEO Spotlight: Gaston Salinas, Botanical Solution Inc. CEO Spotlight: Gaston Salinas, Botanical Solution Inc.
    Emergent BioSolutions, Providence Therapeutics Enter Vaccine Manufacturing Partnership Emergent BioSolutions, Providence Therapeutics Enter Vaccine Manufacturing Partnership
    UK Govt. Terminates Valneva COVID Vax Agreement UK Govt. Terminates Valneva COVID Vax Agreement
    Gaston Salinas Botanical Solution Inc. Gaston Salinas Botanical Solution Inc.
    Resilience to Manufacture mRNA for Moderna’s COVID-19 Vaccine Resilience to Manufacture mRNA for Moderna’s COVID-19 Vaccine
    Pfizer, BioNTech Collaborate with Brazil’s Eurofarma to Manufacture Covid-19 Vaccines Pfizer, BioNTech Collaborate with Brazil’s Eurofarma to Manufacture Covid-19 Vaccines
    J&J Releases COVID-Vax Booster Data J&J Releases COVID-Vax Booster Data
    FDA Approves Pfizer-BioNTech COVID-19 Vaccine COMIRNATY FDA Approves Pfizer-BioNTech COVID-19 Vaccine COMIRNATY
    J&J CEO Alex Gorsky to Step Aside J&J CEO Alex Gorsky to Step Aside

    Related Content

    • Bora Pharmaceuticals

      Bora Pharmaceuticals

      ...
      Lonnie Barish, VP, Business Development 03.09.22

    • Legacy Pharma Solutions

      Legacy Pharma Solutions

      ...
      Nathan Bender, Director, Sales & Marketing 12.07.21

    • Applied Laboratories

      ...
      Andy Murdock, Vice President - Operations 11.03.21


    • Drug Development
      PCI Pharma Services

      PCI Pharma Services

      ...
      Jessica Kloster, Marketing Manager 10.20.21

    • Biologics, Proteins, Vaccines | Breaking News | Industry News
      J&J Data Confirms Strong and Long-Lasting Protection of COVID-19 Vax

      J&J Data Confirms Strong and Long-Lasting Protection of COVID-19 Vax

      Phase 3 ENSEMBLE trial shows booster shot at two months provided 94 percent protection against COVID-19 in the U.S.
      09.21.21

      Loading, Please Wait..
      Trending
      • Vetter’s Newest Clinical Manufacturing Site Completes First Customer Fills
      • Almac Participates In Global Clinical Supply BlockChain Working Group
      • Regulatory Report: Analytical Procedure Development
      • Shimadzu Scientific Instruments Extends HQ Campus
      • Batavia Enters Commercial Manufacturing Business
      Breaking News
      • Takeda to Expand U.S. Footprint
      • Croda Pharma's Lipid Systems Capability to Support mRNA Vaccines
      • WuXi STA Opens High-Potency API Plant
      • Catalent Expands Primary Packaging Capabilities at its Shiga, Japan Facility
      • Phastar Appoints Chris Schoonmaker as Chief Operations Officer
      View Breaking News >
      CURRENT ISSUE

      June 2022

      • Newsmakers: Darren Shirley
      • Are You Prepared for the 2023 DSCSA Deadline?
      • Rethinking the Changing Role of the CRO
      • 23rd Annual Salary Survey
      • Pharma 4.0 and the Modernizing Power of Digital Technology Transfer
      • CEO Spotlight: David Chang
      • Changes are on the Horizon for Single-use Systems in Pharmaceutical Manufacturing
      • CRO Industry Market Report

      Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
      You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

      • About Us
      • Privacy Policy
      • Terms And Conditions
      • Contact Us

      follow us

      Subscribe
      Nutraceuticals World

      Latest Breaking News From Nutraceuticals World

      Pharmavite Expands in Ohio with $200 Million Investment
      Nestlé Health Science Expands in New Zealand with Deal to Buy The Better Health Company
      Younger Consumers Drive Growing Demand for Ingestible Beauty and Skin Care Products
      Coatings World

      Latest Breaking News From Coatings World

      Clariant’s Launches Dispersogen Flex 100
      Lincoln Tech Enters Partnership with AkzoNobel
      AkzoNobel Launches International Interzone 945GF
      Medical Product Outsourcing

      Latest Breaking News From Medical Product Outsourcing

      ENDRA Life Sciences Issued 27th Patent
      AI-Enabled SKOUT Device Improves Colorectal Cancer Screening
      Simon Johnson Appointed as Senior Business Development VP at MedAcuity
      Contract Pharma

      Latest Breaking News From Contract Pharma

      Takeda to Expand U.S. Footprint
      Croda Pharma's Lipid Systems Capability to Support mRNA Vaccines
      WuXi STA Opens High-Potency API Plant
      Beauty Packaging

      Latest Breaking News From Beauty Packaging

      Latest Updates About Cosmoprof North America
      Meet the Clean Beauty Brand for Dogs
      Paco Rabanne Introduces Elle Fanning as Ambassador for New ‘Fame’ Fragrance
      Happi

      Latest Breaking News From Happi

      Two-Part Skincare Product Patented by Estée Lauder Companies
      American Cleaning Institute Pens Letter to Congress Encouraging Examination of Recyclability Improvements
      The Expert Panel for Fragrance Safety Celebrates 55 Years
      Ink World

      Latest Breaking News From Ink World

      INX Launches INXFlex Contour for Shrink Sleeve Market
      Xerox Announces Unexpected Passing of Vice Chairman and CEO John Visentin
      MNYPIA Golf Outing Set to Tee Off on Aug. 17
      Label & Narrow Web

      Latest Breaking News From Label & Narrow Web

      Meyers purchased by third generation of Dillon family
      Epson now shipping ColorWorks C4000 inkjet label printer
      Nobelus launches new films for prime labels
      Nonwovens Industry

      Latest Breaking News From Nonwovens Industry

      What You’re Reading on Nonwovens-Industry.com
      Daio, Livedo Partner to Recycle Diapers
      Suominen Launches Hydraspun Reserve
      Orthopedic Design & Technology

      Latest Breaking News From Orthopedic Design & Technology

      3D Systems and EMS-GRILTECH Enter Strategic Partnership
      AIP Researchers Develop Microfluidic-Based Soft Robotic Prosthetic
      David Sharp Named Global Marketing VP at Catalyst OrthoScience
      Printed Electronics Now

      Latest Breaking News From Printed Electronics Now

      Impinj Launches E910 RFID Reader Chip for Next Generation Enterprise IoT
      onsemi Receives Recognition for Sustainability for Third Straight Year
      Xerox Announces the Unexpected Passing of Vice Chairman and CEO John Visentin

      Copyright © 2022 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

      AD BLOCKER DETECTED

      Our website is made possible by displaying online advertisements to our visitors.
      Please consider supporting us by disabling your ad blocker.


      FREE SUBSCRIPTION Already a subscriber? Login